Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer

You may be eligible if

• DISEASE CHARACTERISTICS:
• Histologically or cytologically confirmed non-small cell lung cancer
• * Clinical stage T1-4, N0-2, M0
• * Clinical stage T1-2, N0-1 must be medically inoperable
• No distant metastases on history and physical exam, CBC, screening profile, CT or MRI of brain, CT of chest and abdomen (including adrenals and liver), and bone scan
• No pleural effusions
• Atelectasis not clearly distinguishable from tumor mass allowed provided all tumor and atelectasis together represent a volume that can be safely treated to the total dose delivered to gross disease
• Diffuse pulmonary infiltrates thought to represent benign disease allowed only if representative lesion samples are proven by biopsy or cytology not to contain cancer
• No diffuse bronchoalveolar carcinoma
• PATIENT CHARACTERISTICS:
• Age:
• 18 and over
• Performance status:
• Karnofsky 70-100%
• Life expectancy:
• Not specified
• Hematopoietic:
• Not specified
• Hepatic:
• Not specified
• Renal:
• Not specified
• Other:
• No other malignancy within the past 5 years except nonmelanomatous skin cancer or noninvasive cervical carcinoma
• No other medical illness that cannot be adequately controlled with appropriate therapy or that is considered severe enough to preclude a radical treatment approach
• PRIOR CONCURRENT THERAPY:
• Biologic therapy
• No prior biologic therapy for lung cancer
• Chemotherapy
• No prior chemotherapy for lung cancer
• Endocrine therapy
• No prior endocrine therapy for lung cancer
• Radiotherapy
• No prior radiotherapy for lung cancer
• Surgery
• No prior surgery for lung cancer